{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:59:32Z","timestamp":1781643572879,"version":"3.54.5"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Guangdong Basic and Applied Basic Research Foundation","award":["2022A1515220191"],"award-info":[{"award-number":["2022A1515220191"]}]},{"name":"the Guangdong Basic and Applied Basic Research Foundation","award":["2022A1515220191"],"award-info":[{"award-number":["2022A1515220191"]}]},{"name":"the Chinese Medicine Guangdong Laboratory","award":["HQL2024PZ001"],"award-info":[{"award-number":["HQL2024PZ001"]}]},{"name":"the Chinese Medicine Guangdong Laboratory","award":["HQL2024PZ001"],"award-info":[{"award-number":["HQL2024PZ001"]}]},{"name":"the State Key Laboratory of Traditional Chinese Medicine Syndrome","award":["SKLKY2025C0009"],"award-info":[{"award-number":["SKLKY2025C0009"]}]},{"name":"the State Key Laboratory of Traditional Chinese Medicine Syndrome","award":["SKLKY2025C0009"],"award-info":[{"award-number":["SKLKY2025C0009"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82304497"],"award-info":[{"award-number":["82304497"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acidic glycosphingolipids (GSLs), including gangliosides (GAs) and sulfatides (STs), play key roles in intercellular signalling and neurodegenerative diseases. However, their comprehensive characterization remains challenging because of structural complexity, abundance variation, and interference from isomers and isotopes. This study aimed to systematically profile GAs and STs in mouse brain tissues and explore their potential as biomarkers in a Parkinson\u2019s disease (PD) model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prefractionation in combination with UHPLC-Q-TOF MS was employed for high-resolution MS and MS\/MS analysis of acidic GSLs. Quantitative structure\u2013retention relationship (QSRR) models were constructed from identified structures and retention times (RTs) to predict RTs and provide complementary support for MS\/MS-based annotation. Dynamic multiple reaction monitoring (dMRM) on UHPLC-QQQ MS was applied to quantify GSLs, followed by a comparative analysis of PD and control mouse brain tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 220 acidic GSLs were characterized, including 173 GAs (21 subclasses) and 47 STs (3 subclasses), representing the most extensive profile reported from mouse brain tissues, among which 75 GAs and 29 STs are, to the best of the authors\u2019 knowledge, newly reported here. The QSRR model provided retention time predictions supporting the tentative annotation of eight rare acidic GSLs with insufficient MS\/MS data. Among the identified species, Monosialogangliosides (GM) were the most abundant subclass, with GM1 and GM3 predominant. GD1a was the major disialoganglioside (GD) species, and the trisialoganglioside (GT), tetrasialoganglioside (GQ), and pentasialoganglioside (GP) subclasses were identified as GT1b, GQ1b, and GP1c, respectively. The STs were mainly of the SulfoHex type. O-acetylation was frequent in GQ species, while fucosylation and GalNAc attachment were primarily associated with GM and GD species. The sphingoid bases were mainly d18:0, d18:1, d20:0, and d20:1, while the N-acyl chains spanned C16:0\u2013C24:0. For quantification, a method covering 17 subclasses enabled the simultaneous measurement of 89 GAs and 27 STs, representing the broadest quantification coverage in PD mouse brain studies to date. Further analysis revealed significant alterations in 20 GAs and 7 STs in PD, with GQ1b reported for the first time as a potential PD-related biomarker, and pathway analysis indicated disruption of b-series GA biosynthesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides a comprehensive profile of acidic GSLs in mouse brain tissues and reveals GQ alterations with pathway disruptions in PD, offering molecular evidence linking acidic GSL metabolism to this disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-026-02918-1","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:26:16Z","timestamp":1774401976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploration of the structural diversity and distribution pattern of gangliosides and sulfatides in mouse brain tissues and biomarkers for Parkinson\u2019s Disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Ming-yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong-yu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-ru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-jun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-fong","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-ran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-ning","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"2918_CR1","doi-asserted-by":"publisher","first-page":"506160","DOI":"10.5402\/2012\/506160","volume":"2012","author":"T Kolter","year":"2012","unstructured":"Kolter T. Ganglioside biochemistry. ISRN Biochem. 2012;2012:506160.","journal-title":"ISRN Biochem"},{"issue":"10","key":"2918_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.5650\/jos.60.537","volume":"60","author":"RK Yu","year":"2011","unstructured":"Yu RK, Tsai YT, Ariga T, Yanagisawa M. Structures, biosynthesis, and functions of gangliosides\u2013an overview. J Oleo Sci. 2011;60(10):537\u201344.","journal-title":"J Oleo Sci"},{"issue":"5","key":"2918_CR3","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.3390\/nu7053891","volume":"7","author":"K Palmano","year":"2015","unstructured":"Palmano K, Rowan A, Guillermo R, Guan J, McJarrow P. The role of gangliosides in neurodevelopment. Nutrients. 2015;7(5):3891\u2013913.","journal-title":"Nutrients"},{"issue":"16","key":"2918_CR4","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1016\/j.jmb.2016.05.020","volume":"428","author":"RL Schnaar","year":"2016","unstructured":"Schnaar RL. Gangliosides of the Vertebrate Nervous System. J Mol Biol. 2016;428(16):3325\u201336.","journal-title":"J Mol Biol"},{"issue":"3","key":"2918_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bbagen.2007.10.008","volume":"1780","author":"A Regina Todeschini","year":"2008","unstructured":"Regina Todeschini A, Hakomori SI. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta. 2008;1780(3):421\u201333.","journal-title":"Biochim Biophys Acta"},{"issue":"23","key":"2918_CR6","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1021\/bi0255874","volume":"41","author":"A Kakio","year":"2002","unstructured":"Kakio A, Nishimoto S, Yanagisawa K, Kozutsumi Y, Matsuzaki K. Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: Importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry-Us. 2002;41(23):7385\u201390.","journal-title":"Biochemistry-Us"},{"key":"2918_CR7","doi-asserted-by":"crossref","unstructured":"Olsen ASB, Faergeman NJ. Sphingolipids: membrane microdomains in brain development, function and neurological diseases. Open Biol. 2017;7(5):170069.","DOI":"10.1098\/rsob.170069"},{"issue":"7","key":"2918_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tibs.2015.03.007","volume":"40","author":"CL Schengrund","year":"2015","unstructured":"Schengrund CL. Gangliosides: glycosphingolipids essential for normal neural development and function. Trends Biochem Sci. 2015;40(7):397\u2013406.","journal-title":"Trends Biochem Sci"},{"key":"2918_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/978-3-030-15950-4_42","volume":"1140","author":"L Dehelean","year":"2019","unstructured":"Dehelean L, Sarbu M, Petrut A, Zamfir AD. Trends in Glycolipid Biomarker Discovery in Neurodegenerative Disorders by Mass Spectrometry. Adv Exp Med Biol. 2019;1140:703\u201329.","journal-title":"Adv Exp Med Biol"},{"key":"2918_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-3-319-06068-2_8","volume":"806","author":"AD Zamfir","year":"2014","unstructured":"Zamfir AD. Neurological Analyses: Focus on Gangliosides and Mass Spectrometry. Advancements Mass Spectrom Biomedical Res. 2014;806:153\u2013204.","journal-title":"Advancements Mass Spectrom Biomedical Res"},{"issue":"5","key":"2918_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10719-019-09885-z","volume":"36","author":"QY Li","year":"2019","unstructured":"Li QY, Sun M, Yu MS, Fu QY, Jiang H, Yu GL, et al. Gangliosides profiling in serum of breast cancer patient: GM3 as a potential diagnostic biomarker. Glycoconj J. 2019;36(5):419\u201328.","journal-title":"Glycoconj J"},{"key":"2918_CR12","doi-asserted-by":"crossref","unstructured":"Sarbu M, Ica R, Zamfir AD. Gangliosides as Biomarkers of Human Brain Diseases: Trends in Discovery and Characterization by High-Performance Mass Spectrometry. Int J Mol Sci. 2022;23(2):693.","DOI":"10.3390\/ijms23020693"},{"issue":"7","key":"2918_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/07328303.2017.1397680","volume":"36","author":"II Cozma","year":"2017","unstructured":"Cozma II, Sarbu M, Ilie C, Zamfir AD. Structural analysis by electrospray ionization mass spectrometry of GT1 ganglioside fraction isolated from fetal brain. J Carbohydr Chem. 2017;36(7):247\u201364.","journal-title":"J Carbohydr Chem"},{"issue":"22","key":"2918_CR14","doi-asserted-by":"publisher","first-page":"12425","DOI":"10.1021\/acs.analchem.7b03523","volume":"89","author":"R Hajek","year":"2017","unstructured":"Hajek R, Jirasko R, Lisa M, Cifkova E, Holcapek M. Hydrophilic Interaction Liquid Chromatography-Mass Spectrometry Characterization of Gangliosides in Biological Samples. Anal Chem. 2017;89(22):12425\u201332.","journal-title":"Anal Chem"},{"issue":"14","key":"2918_CR15","doi-asserted-by":"publisher","first-page":"7808","DOI":"10.1021\/acs.analchem.7b02023","volume":"89","author":"T Hu","year":"2017","unstructured":"Hu T, Jia Z, Zhang JL. Strategy for Comprehensive Profiling and Identification of Acidic Glycosphingolipids Using Ultra-High-Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry. Anal Chem. 2017;89(14):7808\u201316.","journal-title":"Anal Chem"},{"issue":"22","key":"2918_CR16","doi-asserted-by":"publisher","first-page":"8423","DOI":"10.1021\/ac071413m","volume":"79","author":"H He","year":"2007","unstructured":"He H, Conrad CA, Nilsson CL, Ji YJ, Schaub TM, Marshall AG, et al. Method for lipidomic analysis: p53 expression modulation of sulfatide, ganglioside, and phospholipid composition of U87 MG glioblastoma cells. Anal Chem. 2007;79(22):8423\u201330.","journal-title":"Anal Chem"},{"key":"2918_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ab.2017.01.010","volume":"521","author":"M Sarbu","year":"2017","unstructured":"Sarbu M, Dehelean L, Munteanu CVA, Vukelic Z, Zamfir AD. Assessment of ganglioside age-related and topographic specificity in human brain by Orbitrap mass spectrometry. Anal Biochem. 2017;521:40\u201354.","journal-title":"Anal Biochem"},{"issue":"9","key":"2918_CR18","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/jssc.202001248","volume":"44","author":"JY Park","year":"2021","unstructured":"Park JY, Shrestha SA, Cha S. Isomer separation and analysis of amphiphilic polysialogangliosides using reversed-phase liquid chromatography-mass spectrometry. J Sep Sci. 2021;44(9):1843\u201351.","journal-title":"J Sep Sci"},{"issue":"10","key":"2918_CR19","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1021\/acs.analchem.6b00155","volume":"88","author":"M Sarbu","year":"2016","unstructured":"Sarbu M, Robu AC, Ghiulai RM, Vukelic Z, Clemmer DE, Zamfir AD. Electrospray Ionization Ion Mobility Mass Spectrometry of Human Brain Gangliosides. Anal Chem. 2016;88(10):5166\u201378.","journal-title":"Anal Chem"},{"key":"2918_CR20","doi-asserted-by":"publisher","first-page":"104813","DOI":"10.1016\/j.chemphyslip.2019.104813","volume":"225","author":"XY Meng","year":"2019","unstructured":"Meng XY, Yau LF, Huang H, Chan WH, Luo P, Chen L, et al. Improved approach for comprehensive profiling of gangliosides and sulfatides in rat brain tissues by using UHPLC-Q-TOF-MS. Chem Phys Lipids. 2019;225:104813.","journal-title":"Chem Phys Lipids"},{"issue":"15","key":"2918_CR21","doi-asserted-by":"publisher","first-page":"7698","DOI":"10.1021\/acs.analchem.5b01139","volume":"87","author":"F Aicheler","year":"2015","unstructured":"Aicheler F, Li J, Hoene M, Lehmann R, Xu G, Kohlbacher O. Retention Time Prediction Improves Identification in Nontargeted Lipidomics Approaches. Anal Chem. 2015;87(15):7698\u2013704.","journal-title":"Anal Chem"},{"issue":"7","key":"2918_CR22","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1021\/acs.analchem.8b05337","volume":"91","author":"M Lin","year":"2019","unstructured":"Lin M, Wang Z, Wang D, Chen X, Zhang JL. Mathematical Model-Assisted UHPLC-MS\/MS Method for Global Profiling and Quantification of Cholesteryl Esters in Hyperlipidemic Golden Hamsters. Anal Chem. 2019;91(7):4504\u201312.","journal-title":"Anal Chem"},{"issue":"23","key":"2918_CR23","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1007\/s00216-019-01997-7","volume":"411","author":"N Vu","year":"2019","unstructured":"Vu N, Narvaez-Rivas M, Chen GY, Rewers MJ, Zhang Q. Accurate mass and retention time library of serum lipids for type 1 diabetes research. Anal Bioanal Chem. 2019;411(23):5937\u201349.","journal-title":"Anal Bioanal Chem"},{"issue":"1","key":"2918_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00216-021-03492-4","volume":"414","author":"Z Vankova","year":"2022","unstructured":"Vankova Z, Peterka O, Chocholouskova M, Wolrab D, Jirasko R, Holcapek M. Retention dependences support highly confident identification of lipid species in human plasma by reversed-phase UHPLC\/MS. Anal Bioanal Chem. 2022;414(1):319\u201331.","journal-title":"Anal Bioanal Chem"},{"key":"2918_CR25","doi-asserted-by":"crossref","unstructured":"Lee J, Hwang H, Kim S, Hwang J, Yoon J, Yin D et al. Comprehensive Profiling of Surface Gangliosides Extracted from Various Cell Lines by LC-MS\/MS. Cells. 2019;8(11):1323.","DOI":"10.3390\/cells8111323"},{"issue":"15","key":"2918_CR26","doi-asserted-by":"publisher","first-page":"10830","DOI":"10.1021\/acs.analchem.0c02313","volume":"92","author":"H Li","year":"2020","unstructured":"Li H, Xu R, Yang L, Luan H, Chen S, Chen L, et al. Combinatory Data-Independent Acquisition and Parallel Reaction Monitoring Method for Deep Profiling of Gangliosides. Anal Chem. 2020;92(15):10830\u20138.","journal-title":"Anal Chem"},{"issue":"12","key":"2918_CR27","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1007\/s00216-021-03262-2","volume":"413","author":"Z Li","year":"2021","unstructured":"Li Z, Zhang Q. Ganglioside isomer analysis using ion polarity switching liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2021;413(12):3269\u201379.","journal-title":"Anal Bioanal Chem"},{"key":"2918_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.chroma.2018.11.053","volume":"1585","author":"B Buszewski","year":"2019","unstructured":"Buszewski B, Walczak J, Skoczylas M, Haddad PR. High performance liquid chromatography as a molecular probe in quantitative structure-retention relationships studies of selected lipid classes on polar-embedded stationary phases. J Chromatogr A. 2019;1585:105\u201312.","journal-title":"J Chromatogr A"},{"key":"2918_CR29","doi-asserted-by":"crossref","unstructured":"Naylor BC, Catrow JL, Maschek JA, Cox JE. QSRR Automator: A Tool for Automating Retention Time Prediction in Lipidomics and Metabolomics. Metabolites. 2020;10(6):237.","DOI":"10.3390\/metabo10060237"},{"issue":"9\u201310","key":"2918_CR30","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/jssc.202000060","volume":"43","author":"M Witting","year":"2020","unstructured":"Witting M, Bocker S. Current status of retention time prediction in metabolite identification. J Sep Sci. 2020;43(9\u201310):1746\u201354.","journal-title":"J Sep Sci"},{"key":"2918_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.aca.2020.05.051","volume":"1132","author":"RC Barrientos","year":"2020","unstructured":"Barrientos RC, Zhang Q. Recent advances in the mass spectrometric analysis of glycosphingolipidome - A review. Anal Chim Acta. 2020;1132:134\u201355.","journal-title":"Anal Chim Acta"},{"key":"2918_CR32","doi-asserted-by":"publisher","first-page":"124264","DOI":"10.1016\/j.talanta.2023.124264","volume":"256","author":"WH Chan","year":"2023","unstructured":"Chan WH, Yau LF, Meng XY, Chan KM, Jiang ZH, Wang JR. Robust quantitation of gangliosides and sulfatides in human brain using UHPLC-MRM-MS: Method development and application in Alzheimer\u2019s disease. Talanta. 2023;256:124264.","journal-title":"Talanta"},{"issue":"16","key":"2918_CR33","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1007\/s00216-021-03372-x","volume":"413","author":"K Dimovska Nilsson","year":"2021","unstructured":"Dimovska Nilsson K, Karagianni A, Kaya I, Henricsson M, Fletcher JS. (CO(2))(n)(+), (H(2)O)(n)(+), and (H(2)O)(n)(+) (CO(2)) gas cluster ion beam secondary ion mass spectrometry: analysis of lipid extracts, cells, and Alzheimer\u2019s model mouse brain tissue. Anal Bioanal Chem. 2021;413(16):4181\u201394.","journal-title":"Anal Bioanal Chem"},{"key":"2918_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.aca.2020.12.022","volume":"1146","author":"KL Wormwood Moser","year":"2021","unstructured":"Wormwood Moser KL, Van Aken G, DeBord D, Hatcher NG, Maxon L, Sherman M, et al. High-defined quantitative snapshots of the ganglioside lipidome using high resolution ion mobility SLIM assisted shotgun lipidomics. Anal Chim Acta. 2021;1146:77\u201387.","journal-title":"Anal Chim Acta"},{"issue":"7","key":"2918_CR35","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.1021\/acsomega.1c07070","volume":"7","author":"F Huang","year":"2022","unstructured":"Huang F, Bailey LS, Gao T, Jiang W, Yu L, Bennett DA, et al. Analysis and Comparison of Mouse and Human Brain Gangliosides via Two-Stage Matching of MS\/MS Spectra. ACS Omega. 2022;7(7):6403\u201311.","journal-title":"ACS Omega"},{"key":"2918_CR36","doi-asserted-by":"publisher","first-page":"463196","DOI":"10.1016\/j.chroma.2022.463196","volume":"1676","author":"H Li","year":"2022","unstructured":"Li H, Liu Y, Wang Z, Xie Y, Yang L, Zhao Y, et al. Mass spectrometry-based ganglioside profiling provides potential insights into Alzheimer\u2019s disease development. J Chromatogr A. 2022;1676:463196.","journal-title":"J Chromatogr A"},{"key":"2918_CR37","unstructured":"Yang WY. Construction of an siRNA exosome delivery system and its therapeutic effects in alpha-synuclein mutant PD mice [Master\u2019s thesis]. Nanjing: Nanjing University of Chinese Medicine; 2025. Chinese."},{"issue":"1","key":"2918_CR38","doi-asserted-by":"publisher","first-page":"8689","DOI":"10.1038\/s41467-024-53032-8","volume":"15","author":"J Lee","year":"2024","unstructured":"Lee J, Yin D, Yun J, Kim M, Kim SW, Hwang H, et al. Deciphering mouse brain spatial diversity via glyco-lipidomic mapping. Nat Commun. 2024;15(1):8689.","journal-title":"Nat Commun"},{"issue":"7","key":"2918_CR39","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1021\/cr068412z","volume":"107","author":"R Kaliszan","year":"2007","unstructured":"Kaliszan R. QSRR: quantitative structure-(chromatographic) retention relationships. Chem Rev. 2007;107(7):3212\u201346.","journal-title":"Chem Rev"},{"issue":"12","key":"2918_CR40","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1021\/ac5009964","volume":"86","author":"JR Wang","year":"2014","unstructured":"Wang JR, Zhang H, Yau LF, Mi JN, Lee S, Lee KC, et al. Improved sphingolipidomic approach based on ultra-high performance liquid chromatography and multiple mass spectrometries with application to cellular neurotoxicity. Anal Chem. 2014;86(12):5688\u201396.","journal-title":"Anal Chem"},{"key":"2918_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fnins.2018.00045","volume":"12","author":"J Forsayeth","year":"2018","unstructured":"Forsayeth J, Hadaczek P. Ganglioside Metabolism and Parkinson\u2019s Disease. Front Neurosci. 2018;12:45.","journal-title":"Front Neurosci"},{"issue":"1","key":"2918_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-020-00408-1","volume":"15","author":"K Belarbi","year":"2020","unstructured":"Belarbi K, Cuvelier E, Bonte MA, Desplanque M, Gressier B, Devos D, et al. Glycosphingolipids and neuroinflammation in Parkinson\u2019s disease. Mol Neurodegener. 2020;15(1):59.","journal-title":"Mol Neurodegener"},{"key":"2918_CR43","doi-asserted-by":"crossref","unstructured":"Chowdhury S, Ledeen R. The Key Role of GM1 Ganglioside in Parkinson\u2019s Disease. Biomolecules. 2022;12(2):173.","DOI":"10.3390\/biom12020173"},{"issue":"1","key":"2918_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-019-0339-z","volume":"14","author":"M Huebecker","year":"2019","unstructured":"Huebecker M, Moloney EB, van der Spoel AC, Priestman DA, Isacson O, Hallett PJ, et al. Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson\u2019s disease. Mol Neurodegener. 2019;14(1):40.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"2918_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10719-021-10025-9","volume":"39","author":"R Ledeen","year":"2022","unstructured":"Ledeen R, Chowdhury S, Lu ZH, Chakraborty M, Wu G. Systemic deficiency of GM1 ganglioside in Parkinson\u2019s disease tissues and its relation to the disease etiology. Glycoconj J. 2022;39(1):75\u201382.","journal-title":"Glycoconj J"},{"issue":"4","key":"2918_CR46","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/mds.25729","volume":"29","author":"SK Abbott","year":"2014","unstructured":"Abbott SK, Li H, Munoz SS, Knoch B, Batterham M, Murphy KE, et al. Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson\u2019s disease. Mov Disord. 2014;29(4):518\u201326.","journal-title":"Mov Disord"},{"key":"2918_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ab.2014.03.014","volume":"455","author":"Q Huang","year":"2014","unstructured":"Huang Q, Zhou X, Liu D, Xin B, Cechner K, Wang H, et al. A new liquid chromatography\/tandem mass spectrometry method for quantification of gangliosides in human plasma. Anal Biochem. 2014;455:26\u201334.","journal-title":"Anal Biochem"},{"issue":"12","key":"2918_CR48","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/jms.235","volume":"36","author":"JF Nemeth-Cawley","year":"2001","unstructured":"Nemeth-Cawley JF, Karnik S, Rouse JC. Analysis of sulfated peptides using positive electrospray ionization tandem mass spectrometry. J Mass Spectrom. 2001;36(12):1301\u201311.","journal-title":"J Mass Spectrom"},{"issue":"10291","key":"2918_CR49","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Lancet"},{"issue":"10423","key":"2918_CR50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of Parkinson\u2019s disease. Lancet. 2024;403(10423):293\u2013304.","journal-title":"Lancet"},{"issue":"7","key":"2918_CR51","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/10408363.2024.2331471","volume":"61","author":"N Durmaz Celik","year":"2024","unstructured":"Durmaz Celik N, Ozben S, Ozben T. Unveiling Parkinson\u2019s disease through biomarker research: current insights and future prospects. Crit Rev Clin Lab Sci. 2024;61(7):529\u201345.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"2918_CR52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10719-021-10023-x","volume":"39","author":"KL Wallom","year":"2022","unstructured":"Wallom KL, Fernandez-Suarez ME, Priestman DA, Te Vruchte D, Huebecker M, Hallett PJ, et al. Glycosphingolipid metabolism and its role in ageing and Parkinson\u2019s disease. Glycoconj J. 2022;39(1):39\u201353.","journal-title":"Glycoconj J"},{"issue":"12","key":"2918_CR53","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1194\/jlr.M500252-JLR200","volume":"46","author":"X Chen","year":"2005","unstructured":"Chen X, Chi S, Liu M, Yang W, Wei T, Qi Z, et al. Inhibitory effect of ganglioside GD1b on K+ current in hippocampal neurons and its involvement in apoptosis suppression. J Lipid Res. 2005;46(12):2580\u20135.","journal-title":"J Lipid Res"},{"issue":"1","key":"2918_CR54","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/jb\/mvs055","volume":"152","author":"Y Kanatsu","year":"2012","unstructured":"Kanatsu Y, Chen NH, Mitoma J, Nakagawa T, Hirabayashi Y, Higashi H. Gangliosides stimulate bradykinin B2 receptors to promote calmodulin kinase II-mediated neuronal differentiation. J Biochem. 2012;152(1):63\u201372.","journal-title":"J Biochem"},{"issue":"10","key":"2918_CR55","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/glycob\/cws103","volume":"22","author":"ER Sturgill","year":"2012","unstructured":"Sturgill ER, Aoki K, Lopez PH, Colacurcio D, Vajn K, Lorenzini I, et al. Biosynthesis of the major brain gangliosides GD1a and GT1b. Glycobiology. 2012;22(10):1289\u2013301.","journal-title":"Glycobiology"},{"issue":"10","key":"2918_CR56","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.29163","volume":"37","author":"D Te Vruchte","year":"2022","unstructured":"Te Vruchte D, Sturchio A, Priestman DA, Tsitsi P, Hertz E, Andreasson M, et al. Glycosphingolipid Changes in Plasma in Parkinson\u2019s Disease Independent of Glucosylceramide Levels. Mov Disord. 2022;37(10):2129\u201334.","journal-title":"Mov Disord"},{"issue":"1","key":"2918_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/glia.10047","volume":"38","author":"JK Ryu","year":"2002","unstructured":"Ryu JK, Shin WH, Kim J, Joe EH, Lee YB, Cho KG, et al. Trisialoganglioside GT1b induces in vivo degeneration of nigral dopaminergic neurons: role of microglia. Glia. 2002;38(1):15\u201323.","journal-title":"Glia"},{"issue":"3","key":"2918_CR58","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.brainresrev.2004.07.014","volume":"46","author":"L Colombaioni","year":"2004","unstructured":"Colombaioni L, Garcia-Gil M. Sphingolipid metabolites in neural signalling and function. Brain Res Brain Res Rev. 2004;46(3):328\u201355.","journal-title":"Brain Res Brain Res Rev"},{"issue":"5","key":"2918_CR59","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/glycob\/12.5.339","volume":"12","author":"S Fujii","year":"2002","unstructured":"Fujii S, Igarashi K, Sasaki H, Furuse H, Ito K, Kaneko K, et al. Effects of the mono- and tetrasialogangliosides GM1 and GQ1b on ATP-induced long-term potentiation in hippocampal CA1 neurons. Glycobiology. 2002;12(5):339\u201344.","journal-title":"Glycobiology"},{"issue":"1","key":"2918_CR60","doi-asserted-by":"publisher","first-page":"8512","DOI":"10.1038\/s41598-019-44739-6","volume":"9","author":"MK Shin","year":"2019","unstructured":"Shin MK, Choi MS, Chae HJ, Kim JW, Kim HG, Kim KL. Ganglioside GQ1b ameliorates cognitive impairments in an Alzheimer\u2019s disease mouse model, and causes reduction of amyloid precursor protein. Sci Rep. 2019;9(1):8512.","journal-title":"Sci Rep"},{"issue":"6","key":"2918_CR61","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1111\/j.1471-4159.1985.tb10529.x","volume":"45","author":"E Berry-Kravis","year":"1985","unstructured":"Berry-Kravis E, Dawson G. Possible role of gangliosides in regulating an adenylate cyclase-linked 5-hydroxytryptamine (5-HT1) receptor. J Neurochem. 1985;45(6):1739\u201347.","journal-title":"J Neurochem"},{"issue":"2","key":"2918_CR62","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.neulet.2008.05.020","volume":"439","author":"WR Jung","year":"2008","unstructured":"Jung WR, Kim HG, Kim KL. Ganglioside GQ1b improves spatial learning and memory of rats as measured by the Y-maze and the Morris water maze tests. Neurosci Lett. 2008;439(2):220\u20135.","journal-title":"Neurosci Lett"},{"key":"2918_CR63","doi-asserted-by":"crossref","unstructured":"Herrera-Marcos LV, Sahali D, Ollero M. 9-O Acetylated Gangliosides in Health and Disease. Biomolecules. 2023;13(5):827.","DOI":"10.3390\/biom13050827"},{"issue":"1","key":"2918_CR64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ijc.21788","volume":"119","author":"B Kniep","year":"2006","unstructured":"Kniep B, Kniep E, Ozkucur N, Barz S, Bachmann M, Malisan F, et al. 9-O-acetyl GD3 protects tumor cells from apoptosis. Int J Cancer. 2006;119(1):67\u201373.","journal-title":"Int J Cancer"},{"issue":"1","key":"2918_CR65","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41531-023-00558-1","volume":"9","author":"I Kaya","year":"2023","unstructured":"Kaya I, Nilsson A, Luptakova D, He Y, Vallianatou T, Bjarterot P, et al. Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson\u2019s disease primate model. NPJ Parkinsons Dis. 2023;9(1):118.","journal-title":"NPJ Parkinsons Dis"},{"issue":"11","key":"2918_CR66","doi-asserted-by":"publisher","first-page":"8077","DOI":"10.4049\/jimmunol.181.11.8077","volume":"181","author":"SB Jeon","year":"2008","unstructured":"Jeon SB, Yoon HJ, Park SH, Kim IH, Park EJ. Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells. J Immunol. 2008;181(11):8077\u201387.","journal-title":"J Immunol"},{"issue":"8","key":"2918_CR67","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1194\/jlr.R026682","volume":"53","author":"T Takahashi","year":"2012","unstructured":"Takahashi T, Suzuki T. Role of sulfatide in normal and pathological cells and tissues. J Lipid Res. 2012;53(8):1437\u201350.","journal-title":"J Lipid Res"},{"key":"2918_CR68","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-94-007-6331-9_3","volume":"991","author":"S Xiao","year":"2013","unstructured":"Xiao S, Finkielstein CV, Capelluto DG. The enigmatic role of sulfatides: new insights into cellular functions and mechanisms of protein recognition. Adv Exp Med Biol. 2013;991:27\u201340.","journal-title":"Adv Exp Med Biol"},{"key":"2918_CR69","doi-asserted-by":"crossref","unstructured":"Angelopoulou E, Paudel YN, Villa C, Piperi C. Arylsulfatase A (ASA) in Parkinson\u2019s Disease: From Pathogenesis to Biomarker Potential. Brain Sci. 2020;10(10):713.","DOI":"10.3390\/brainsci10100713"},{"key":"2918_CR70","doi-asserted-by":"publisher","first-page":"1078854","DOI":"10.3389\/fnmol.2022.1078854","volume":"15","author":"JS Schneider","year":"2022","unstructured":"Schneider JS, Singh G. Altered expression of glycobiology-related genes in Parkinson\u2019s disease brain. Front Mol Neurosci. 2022;15:1078854.","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"2918_CR71","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1152\/physrev.00033.2013","volume":"94","author":"RL Schnaar","year":"2014","unstructured":"Schnaar RL, Gerardy-Schahn R, Hildebrandt H. Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. Physiol Rev. 2014;94(2):461\u2013518.","journal-title":"Physiol Rev"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-02918-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02918-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02918-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:48:26Z","timestamp":1781642906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-02918-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2918"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-02918-1","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}